Chronic, topical administration of 4-aminobiphenyl induces tissue-specific DNA adducts in mice

Toxicology and Applied Pharmacology

Volumn 144, Issue 2, 1997, Pages 325-331

  Underwood, Patricia M ^a,b   Zhou, Qing ^a   Jaeger, Marlene ^a   Reilman, Ray ^a   Pinney, Susan ^a   Warshawsky, David ^a   Talaska, Glenn ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b McLaren and Hart Inc USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BLADDER; CONTROLLED STUDY; DNA ADDUCT; FEMALE; LIVER; LUNG; METABOLIC ACTIVATION; MOUSE; NONHUMAN; SKIN; TOPICAL DRUG ADMINISTRATION;

EID: 0031172395     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8158     Document Type: Article

References (31)

1. Bartsch, H., Malaveille, C., Friesen, M., Kadlubar, F. F., and Vineis, P. (1993). Black (aircured) and blond (fluecured) tobacco-cancer risk: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur. J. Cancer. 29A, 1199-1207.
2. Bookland, E. A., Swaminathan, S., Oyasu, R., Gilchrist, K. W., Lindstrom, M., and Reznikoff, C. A. (1992). Tumorigenic transformation and neoplastic progression of human urothelial cells after exposure in vitro to 4-aminobiphenyl or its metabolites. Cancer Res. 52, 1606-1614.
3. Brill, E., Radomski, J. L., and MacDonald, W. E. (1977). Failure of the N-oxidized metabolites of some carcinogenic amines to induce tumors in normal and wounded rat skin. Res. Commun. Chem. Pathol. Pharmacol. 18(2), 353-360.
4. Bryant, M. S., Skipper, P. L., Tannenbaum, S. R., and Maclure, M. (1987). Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 47, 602-608.
5. Butler, M. A., Guengerich, F. P., and Kadlubar, F. F. (1989a). Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylenebis(2)-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome p-450 monooxygenases. Cancer Res. 49, 25-31.
6. Butler, M. A., Iwasaki, M., Guengerich, F. P., and Kadlubar, F. F. (1989b). Human cytochrome P-450PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 86, 7696-7700.
7. Flammang, T. J., and Kadlubar, F. F. (1986). Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2′-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyl transferases. Carcinogenesis 7, 919-926.
8. 32P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res. 5, 5656-5662.
9. Hammond, S. K., Coghlin, J., Gann, P. H., Paul, M., Taghizadeh, K., Skipper, P. L., and Tannenbaum, S. R. (1993). Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J. Natl. Cancer Inst. 85, 474-477.
10. Jugert, F. K., Agarwal, R., Kuhn, A., Bickers, D. R., Merk, H. F., and Mukhtar, H. (1994). Multiple cytochrome P450 Isozymes in murine skin: Induction of P4501A, 2B, 2E, and 3A by dexamethasone. J. Invest. Derm. 102, 970-975.
11. Kadlubar, F. F., Dooley, K. L., Benson, R. W., Roberts, D. W., Butler, M. A., Teitel, C. H., Bailey, J. R., and Young, J. F. (1988). Pharmacokinetic models of aromatic amine-induced urinary bladder carcinogenesis in beagle dogs administered 4-aminobiphenyl. In Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes (King, C. M., Romano, L. J., and Schuetzle, D., Eds.), pp. 173-180. Elsevier Science, New York.
12. Kadlubar, F. F., Dooley, K. L., Teitel, C. H., Roberts, D. W., Bensen, R. W., Butler, M. A., Bailey, J. R., Young, J. F., Skipper, P. W., and Tannenbaum, S. R. (1991). Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. Cancer Res. 51, 4371-4377.
13. Kawakubo, Y., Manabe, S., Yamazoe, Y., Nishikawa, T., and Kato, R. (1988). Properties of cutaneous acetyltransferase catalyzing N-and O-acetylation of carcinogenic arylamines and n-hydroxyarylamine. J. Invest. Derm. 33, 265-270.
14. Kleinbaum, D. G., and Kupper, L. L. (1978). Applied. Regression and Other Multivariate Models, Chap. 8, pp. 95-112. Duxbury Press, North Scituate, MA.
15. Kriek, E. (1983). Reactive forms of aromatic amines and amides: chemical and structural features in relation to carcinogenesis. In 13th International Cancer Congress. B. Biology of Cancer (1) (Mirand, E. A., Hutchinson, W. B., and Mihich, E., Eds.), pp. 161-174. A. R. Liss, New York.
16. Krishna, D. R., and Klotz, U. (1994). Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet. 26, 144-160.
17. Melchior, W. B., Marques, M. M., and Beland, F. F. (1994). Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis 15, 889-899.
18. Nebert, D. W., and McKinnon, R. A. (1994). Cytochrome P450: Evolution and functional diversity. Prog. Liver Dis. 12, 63-97.
19. Poirier, M. C., Fullerton, N. F., Smith, B. A., and Beland, F. A. (1995). DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels, Carcinogenesis 16, 2917-2921.
20. Randerath, E., Mittal, D., and Randerath, K. (1989). Tissue distribution of covalent DNA damage in mice treated dermally with cigarette 'tar': Preference for lung and heart DNA. Carcinogenesis 9, 786-790.
21. Schaffler, G., Betz, C., Roger, E. (1993). Mass spectrometric analysis of tobacco-specific hemoglobin adducts. Environ. Health Perspect. 99, 187-189.
22. Schieferstein, G. J., Littlefield, N. A., Gaylor, D. W., Sheldon, W. G., and Burger, G. T. (1985). Carcinogenesis of 4-aminobiphenyl in BALB/ cStCrlfC3hf/NCTR mice. Eur. J. Cancer Clin. Oncol. 21, 865-873.
23. Scott, T. S. (1962). Carcinogenic and chronic toxic hazards of aromatic amines. In Elsevier Monographs on Toxic Agents (Browning, E., Ed.), p. 11. Elsevier, New York.
24. Shah, P. V., and Guthrie, F. E. (1983). Dermal absorption of benzidine derivatives in rats. Bull. Environ. Contam. Toxicol. 31, 73-78.
25. 32P-Postlabeling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans. J. Chromatogr. 580, 293-323.
26. Talaska, G., Al-Juburi, A. Z., and Kadlubar, F. F. (1991). Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: Identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. USA 88, 5350-5354.
27. 32P-postlabeling and subsequent thin-layer and high-pressure liquid chromatography. Carcinogenesis 11, 639-646.
28. Talaska, G., Jaeger, M., Reilman, R., Collins, T., and Warshawsky, D. (1996). Chronic, topical exposure to benzo[a]pyrene induces relatively high steady state levels of DNA adducts in target tissues and alters kinetics of adduct loss. Proc. Natl. Acad. Sci. USA 93, 7789-7793.
29. Talaska, G., Schamer, M., Skipper, P., Tannenbaum, S., Caporaso, N., Unruh, L., Kadlubar, F., Bartsch, H., Malaveille, C., and Vineis, P. (1993). Carcinogen-DNA adducts in exfoliated urothelial cells: Techniques for non-invasive human monitoring. Environ. Health Perspect. 99, 289-291.
30. Talaska, G., Schamer, M., Casetta, G., Tizzani, A., and Vineis, P. (1994). Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise. Cancer Lett. 84, 93-97.
31. Underwood, P. M., Zhou, Q., Jaeger, M., Vasiliou, V., Nebert, D. W., and Talaska, G. (1996). 4-Aminobiphenyl DNA adduct formation in the CYP1A2(-/-) knockout mouse. Toxicologist 30, 281.